Cite
HARVARD Citation
Ribera, J. et al. (2022). Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols. British journal of haematology. pp. 670-675. [Online].